Doxycycline is a broad-spectrum antibiotic belonging to the tetracycline class, developed in the 1960s and approved for medical use shortly thereafter. It has been widely used to treat a variety of bacterial infections, including respiratory tract infections, skin conditions, sexually transmitted infections, and certain zoonotic diseases such as malaria and Lyme disease. Its history is marked by its effectiveness and versatility, as well as its role in both treatment and prevention of infections. Doxycycline works by inhibiting bacterial protein synthesis, thereby stopping the growth of bacteria. Over time, its use has been refined to minimize side effects such as photosensitivity and gastrointestinal discomfort, and it remains an essential medication in global health due to its affordability and broad applicability.
BRAND NAMES
Vibramycin
Doryx
Monodox
Oracea
MECHANISM OF ACTION
Doxycycline acts by inhibiting bacterial protein synthesis, which prevents the growth and multiplication of bacteria. It specifically binds to the 30S subunit of the bacterial ribosome, blocking the attachment of aminoacyl-tRNA to the mRNA-ribosome complex. This interference stops the addition of amino acids to the growing peptide chain, thereby halting protein production.
PHARMACOKINETICS
Absorption
Doxycycline is well absorbed from the gastrointestinal tract after oral administration, with a high bioavailability of about 90–100%. Unlike older tetracyclines, its absorption is not significantly affected by food, although very heavy meals may slightly delay the rate of absorption.
Distribution
Doxycycline has a relatively large volume of distribution (Vd), typically around 0.7–1 L/kg, indicating that it is extensively distributed into body tissues rather than remaining confined to the plasma.
Metabolism
Doxycycline undergoes minimal hepatic metabolism compared to other tetracyclines. Most of the drug remains unchanged in the body, which contributes to its longer half-life and predictable pharmacokinetics. Because it is not extensively metabolized by the liver, doxycycline is less affected by hepatic enzyme induction or inhibition, reducing the risk of significant drug interactions.
Elimination
Doxycycline is eliminated from the body through a combination of renal and non-renal routes, with the majority excreted in feces via bile and a smaller portion in urine. Unlike other tetracyclines, it does not require dose adjustment in mild to moderate renal impairment, as renal clearance is relatively low.
PHARMACODYNAMICS
Its primary mechanism of action involves inhibition of bacterial protein synthesis: doxycycline binds reversibly to the 30S ribosomal subunit, preventing the attachment of aminoacyl-tRNA to the mRNA-ribosome complex.
ADMINISTRATION
Doxycycline can be administered via oral or intravenous routes, with oral administration being the most common. It is available in tablets, capsules, and oral suspension, as well as IV infusion for hospitalized patients. For optimal absorption, doxycycline should be taken with a full glass of water and either 1 hour before or 2 hours after meals, although food only minimally affects its absorption.
DOSAGE AND STRENGTH
Doxycycline is available in oral tablets and capsules of 50 mg and 100 mg, oral suspension (25 mg/5 mL or 100 mg/5 mL), and intravenous injection of 100 mg/5 mL. For most adults, the usual regimen is a loading dose of 100 mg every 12 hours on the first day, followed by 100 mg once or twice daily depending on the infection’s severity.
DRUG INTERACTIONS
Doxycycline can interact with several drugs and substances that may reduce its absorption or alter its effects. Co-administration with antacids, calcium, magnesium, iron supplements, or multivitamins can form non-absorbable chelates, significantly reducing its oral bioavailability. Concurrent use with warfarin may increase the risk of bleeding by enhancing anticoagulant effects.
FOOD INTERACTIONS
Doxycycline absorption is generally not significantly affected by food, making it more convenient than older tetracyclines. However, very heavy or high-fat meals may slightly delay absorption, though the overall bioavailability remains high. More importantly, foods or drinks containing calcium (dairy products), magnesium, or iron can bind doxycycline in the gut, forming insoluble complexes that reduce its absorption and effectiveness.
CONTRAINDICATIONS
Doxycycline is contraindicated in patients with a known hypersensitivity to doxycycline, other tetracyclines, or any component of the formulation. It should not be used in children under 8 years of age due to the risk of permanent teeth discoloration and enamel hypoplasia, except in life-threatening situations.
SIDE EFFECTS
Nausea and vomiting
Diarrhea or upset stomach
Loss of appetite
Esophageal irritation or ulceration.
OVER DOSAGE
Overdosage of doxycycline can occur accidentally or intentionally, leading to gastrointestinal symptoms such as nausea, vomiting, diarrhea, and abdominal pain, as well as esophageal irritation or ulceration. In severe cases, it may cause hepatotoxicity, renal impairment, electrolyte imbalance, and, rarely, intracranial hypertension.
TOXICITY
Doxycycline toxicity can result from acute overdose or prolonged high-dose therapy. It primarily affects the gastrointestinal system, causing nausea, vomiting, diarrhea, and esophageal irritation. Hepatotoxicityis a serious but rare complication, especially in patients with preexisting liver disease or those receiving high doses. Other toxic effects includephotosensitivity reactions, intracranial hypertension (manifested by headache and visual disturbances), and renal impairment in susceptible individuals.
